Search research articles
Contact Us
Filters
Showing results (81-90 of 196) with videos related to
Page
of 20
Sort By:
Oncoimmunology
|
September 14, 2020
IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice
Leland G Richardson, Linda T Nieman, Anat O Stemmer-Rachamimov, et al.
Acta Neuropathologica Communications
|
October 22, 2020
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic
Erik A Williams, Sandro Santagata, Hiroaki Wakimoto, et al.
Journal of Oncology Practice
|
January 26, 2019
Performance of a Hospital Pathway for Patients With a New Single Brain Mass
Isabel Arrillaga-Romany, William T Curry, Justin T Jordan, et al.
Neuro-Oncology
|
November 30, 2018
Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma
Tejus A Bale, Justin T Jordan, Otto Rapalino, et al.
NMR in Biomedicine
|
October 5, 2021
Improving D-2-hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF-receive/B<sub>0</sub> -shim array coils at 3 T
Bernhard Strasser, Nicolas S Arango, Jason P Stockmann, et al.
Journal of Neuro-Oncology
|
September 13, 2018
The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study
Xiaojie Ding, Zheng Wang, Di Chen, et al.
The Oncologist
|
February 24, 2019
Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic Control
Christopher Alvarez-Breckenridge, Anita Giobbie-Hurder, Corey M Gill, et al.
Nature Communications
|
April 18, 2018
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate
Ovidiu C Andronesi, Isabel C Arrillaga-Romany, K Ina Ly, et al.
Journal of Neurosurgery
|
March 30, 2019
Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mapping
Bryan D Choi, Daniel K Lee, Jimmy C Yang, et al.
Cancer Cell
|
October 3, 2017
Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma
Christian J Braun, Monica Stanciu, Paul L Boutz, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 196) with videos related to
Sort By:
Page
of 20
Oncoimmunology
|
September 14, 2020
IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice
Leland G Richardson, Linda T Nieman, Anat O Stemmer-Rachamimov, et al.
Acta Neuropathologica Communications
|
October 22, 2020
Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic
Erik A Williams, Sandro Santagata, Hiroaki Wakimoto, et al.
Journal of Oncology Practice
|
January 26, 2019
Performance of a Hospital Pathway for Patients With a New Single Brain Mass
Isabel Arrillaga-Romany, William T Curry, Justin T Jordan, et al.
Neuro-Oncology
|
November 30, 2018
Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma
Tejus A Bale, Justin T Jordan, Otto Rapalino, et al.
NMR in Biomedicine
|
October 5, 2021
Improving D-2-hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF-receive/B<sub>0</sub> -shim array coils at 3 T
Bernhard Strasser, Nicolas S Arango, Jason P Stockmann, et al.
Journal of Neuro-Oncology
|
September 13, 2018
The prognostic value of maximal surgical resection is attenuated in oligodendroglioma subgroups of adult diffuse glioma: a multicenter retrospective study
Xiaojie Ding, Zheng Wang, Di Chen, et al.
The Oncologist
|
February 24, 2019
Upfront Surgical Resection of Melanoma Brain Metastases Provides a Bridge Toward Immunotherapy-Mediated Systemic Control
Christopher Alvarez-Breckenridge, Anita Giobbie-Hurder, Corey M Gill, et al.
Nature Communications
|
April 18, 2018
Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate
Ovidiu C Andronesi, Isabel C Arrillaga-Romany, K Ina Ly, et al.
Journal of Neurosurgery
|
March 30, 2019
Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mapping
Bryan D Choi, Daniel K Lee, Jimmy C Yang, et al.
Cancer Cell
|
October 3, 2017
Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma
Christian J Braun, Monica Stanciu, Paul L Boutz, et al.
Page
of 20